What is the ROCE (Return on Capital Employed) of Novocure this year?
The ROCE of Novocure is -0.47 undefined this year.
Novocure ROCE 2025
Novocure ROCE
-0.47
Ticker
NVCR
ISIN
JE00BYSS4X48
WKN
A140ML
In 2025, Novocure's return on capital employed (ROCE) was -0.47, a -27.18% increase from the -0.64 ROCE in the previous year.
Novocure Aktienanalyse
What does Novocure do?
Novocure Ltd. is a global scientific-based company that was founded in Israel in 2000. Its focus was originally on researching and developing tumor therapies. Since then, Novocure has become one of the leading companies in cancer research and treatment, specializing in the development of innovative cancer therapies. The business model of Novocure is based on developing powerful and innovative treatment methods for a variety of cancer types, including brain, pancreatic, prostate, and lung cancer. The company is committed to developing new cancer treatments that improve the lives of patients and meet their needs. Novocure also offers a wide range of products, including several treatment options based on the use of electric fields. These electric fields can specifically target the tumor and inhibit cell division without damaging the surrounding healthy tissue. This innovative technology is also called "tumor therapeutic fields" (TTF). TTF is a non-invasive procedure that is able to destroy cancer cells and inhibit the growth of cancer cells using targeted radio waves. The company also has its own research and development department dedicated to the development of innovative cancer therapies. In collaboration with numerous leading medical experts and researchers worldwide, Novocure advances cancer treatment research and development, striving to improve the treatment of cancer patients worldwide. Novocure operates three main divisions: Onco-Support, Onco-Centers, and Medical Research. The Onco-Support division offers specialized services to patients, such as training on the use of TTF devices, assistance with insurance issues, facilitating access to TTF devices, and help with setting up TTF devices. The Onco-Centers division operates various clinics specialized in the treatment of skin and brain cancer. Here, patients can benefit from the use of TTF devices and receive this therapy from experienced specialists. The Onco-Centers also provide tailored support and counseling for the needs of patients. The Medical Research division of the company also conducts research and development activities in the field of cancer therapies. Here, new therapies and procedures for cancer treatment are explored and developed, with a particular focus on the application of TTF devices. The goal of this research is to develop innovative cancer treatments that improve the lives of cancer patients and give them hope for a better future. Overall, Novocure Ltd. is an innovative and customer-oriented company dedicated to the treatment of cancer patients. The company invests heavily in research and development to develop innovative therapies and products that meet the high needs of cancer patients. The use of TTF technology is a significant step in cancer treatment, and Novocure Ltd. is leading the global development in this regard. Novocure ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Novocure's Return on Capital Employed (ROCE)
Novocure's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Novocure's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Novocure's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Novocure’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Novocure stock
How has the ROCE (Return on Capital Employed) of Novocure developed compared to the previous year?
The ROCE of Novocure has increased by -27.18% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Novocure?
A high Return on Capital Employed (ROCE) indicates that Novocure has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Novocure?
A low ROCE (Return on Capital Employed) can indicate that Novocure has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Novocure impact the company?
An increase in the ROCE of Novocure can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Novocure affect the company?
A decrease in ROCE of Novocure can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Novocure?
Some factors that can affect Novocure's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Novocure so important for investors?
The ROCE of Novocure is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Novocure take to improve the ROCE?
To improve the ROCE, Novocure can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Novocure pay?
Over the past 12 months, Novocure paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Novocure is expected to pay a dividend of 0 USD.
What is the dividend yield of Novocure?
The current dividend yield of Novocure is .
When does Novocure pay dividends?
Novocure pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Novocure?
Novocure paid dividends every year for the past 0 years.
What is the dividend of Novocure?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Novocure located?
Novocure is assigned to the 'Health' sector.
Wann musste ich die Aktien von Novocure kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Novocure from 7/28/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/28/2025.
When did Novocure pay the last dividend?
The last dividend was paid out on 7/28/2025.
What was the dividend of Novocure in the year 2024?
In the year 2024, Novocure distributed 0 USD as dividends.
In which currency does Novocure pay out the dividend?
The dividends of Novocure are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Novocure
Our stock analysis for Novocure Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novocure Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.